İ. Orhan, "Implications of some selected flavonoids towards Alzheimer's disease with the emphasis on cholinesterase inhibition and their bioproduction by metabolic engineering," Current Pharmaceutical Biotechnology , vol.15, no.4, pp.352-361, 2014
Orhan, İ. 2014. Implications of some selected flavonoids towards Alzheimer's disease with the emphasis on cholinesterase inhibition and their bioproduction by metabolic engineering. Current Pharmaceutical Biotechnology , vol.15, no.4 , 352-361.
Orhan, İ., (2014). Implications of some selected flavonoids towards Alzheimer's disease with the emphasis on cholinesterase inhibition and their bioproduction by metabolic engineering. Current Pharmaceutical Biotechnology , vol.15, no.4, 352-361.
Orhan, İLKAY. "Implications of some selected flavonoids towards Alzheimer's disease with the emphasis on cholinesterase inhibition and their bioproduction by metabolic engineering," Current Pharmaceutical Biotechnology , vol.15, no.4, 352-361, 2014
Orhan, İLKAY E. . "Implications of some selected flavonoids towards Alzheimer's disease with the emphasis on cholinesterase inhibition and their bioproduction by metabolic engineering." Current Pharmaceutical Biotechnology , vol.15, no.4, pp.352-361, 2014
Orhan, İ. (2014) . "Implications of some selected flavonoids towards Alzheimer's disease with the emphasis on cholinesterase inhibition and their bioproduction by metabolic engineering." Current Pharmaceutical Biotechnology , vol.15, no.4, pp.352-361.
@article{article, author={İLKAY ERDOĞAN ORHAN}, title={Implications of some selected flavonoids towards Alzheimer's disease with the emphasis on cholinesterase inhibition and their bioproduction by metabolic engineering}, journal={Current Pharmaceutical Biotechnology}, year=2014, pages={352-361} }